Literature DB >> 18216392

An efficient and fully automated high-throughput transfection method for genome-scale siRNA screens.

Namjin Chung1, Louis Locco, Kevin W Huff, Steven Bartz, Peter S Linsley, Marc Ferrer, Berta Strulovici.   

Abstract

RNA interference (RNAi), combined with the availability of genome sequences, provides an unprecedented opportunity for the massive and parallel investigations of gene function. Small interfering RNA (siRNA) represents a popular and quick approach of RNAi for in vitro loss-of-function genetic screens. Efficient transfection of siRNA is critical for unambiguous interpretation of screen results and thus overall success of any siRNA screen. A high-throughput, lipid-based transfection method for siRNA was developed that can process eighty 384-well microplates in triplicate (for a total of 30,720 unique transfections) in 8 h. Transfection throughput was limited only by the speed of robotics, whereas the cost of screening was reduced. As a proof of principle, a genome-scale screen with a library of 22,108 siRNAs was performed to identify the genes sensitizing cells to mitomycin C at concentrations of 0, 20, and 60 nM. Transfection efficiency, performances of control siRNAs, and other quality metrics were monitored and demonstrated that the new, optimized transfection protocol produced high-quality results throughout the screen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216392     DOI: 10.1177/1087057107312032

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  8 in total

1.  RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.

Authors:  S E Martin; Z-H Wu; K Gehlhaus; T L Jones; Y-W Zhang; R Guha; S Miyamoto; Y Pommier; N J Caplen
Journal:  Curr Cancer Drug Targets       Date:  2011-10       Impact factor: 3.428

2.  An automated method to evaluate the enzyme kinetics of β-glucosidases.

Authors:  Pavel Klimeš; Pavel Mazura; Dušan Turek; Břetislav Brzobohatý
Journal:  Protein Sci       Date:  2016-11-24       Impact factor: 6.725

3.  Computer controlled automated assay for comprehensive studies of enzyme kinetic parameters.

Authors:  Felix Bonowski; Ana Kitanovic; Peter Ruoff; Jinda Holzwarth; Igor Kitanovic; Van Ngoc Bui; Elke Lederer; Stefan Wölfl
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 4.  Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

Authors:  Silvia Cermelli; In Sock Jang; Brady Bernard; Carla Grandori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

5.  First siRNA library screening in hard-to-transfect HUVEC cells.

Authors:  Markus Zumbansen; Ludger M Altrogge; Nicole Ue Spottke; Sonja Spicker; Sheila M Offizier; Sandra Bs Domzalski; Allison L St Amand; Andrea Toell; Devin Leake; Herbert A Mueller-Hartmann
Journal:  J RNAi Gene Silencing       Date:  2009-10-29

6.  Valspodar limits human cytomegalovirus infection and dissemination.

Authors:  Andrea J Parsons; Tobias Cohen; Toni M Schwarz; Kathryn R Stein; Sabrina I Ophir; Jailene Paredes Casado; Domenico Tortorella
Journal:  Antiviral Res       Date:  2021-06-28       Impact factor: 10.103

7.  High-throughput screening of effective siRNAs using luciferase-linked chimeric mRNA.

Authors:  Shen Pang; Lauren Pokomo; Kevin Chen; Masakazu Kamata; Si-Hua Mao; Hong Zhang; Elliot Razi; Dong Sung An; Irvin S Y Chen
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

8.  MasterPATH: network analysis of functional genomics screening data.

Authors:  Natalia Rubanova; Guillaume Pinna; Jeremie Kropp; Anna Campalans; Juan Pablo Radicella; Anna Polesskaya; Annick Harel-Bellan; Nadya Morozova
Journal:  BMC Genomics       Date:  2020-09-14       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.